Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray

Int J Cardiol. 2013 Apr 5;164(2):e17-8. doi: 10.1016/j.ijcard.2012.09.136. Epub 2012 Oct 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Inhalation
  • Administration, Topical
  • Adrenergic alpha-Agonists / administration & dosage
  • Adrenergic alpha-Agonists / adverse effects*
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / diagnosis*
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects*
  • Male
  • Middle Aged
  • Nasal Decongestants / administration & dosage
  • Nasal Decongestants / adverse effects*

Substances

  • Adrenergic alpha-Agonists
  • Imidazoles
  • Nasal Decongestants
  • xylometazoline